To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis
Launched by BAYER · Apr 21, 2015
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Asian Female patients at least 18 years of age
- • Clinical or surgical diagnosis of endometriosis (depending on local approved indication) : Clinical diagnosis by suggestive symptoms and positive finding in imaging study (Chocolate cyst)
- • Patients with Endometriosis associated pelvic pain
- • Decision taken by the physician to newly prescribe Visanne®
- • Availability of a signed informed consent
- Exclusion Criteria:
- • Patients participating in an investigational program with interventions outside of routine clinical practice
- • Patients for whom any of contraindication listed in the local summary of product characteristics (SPC) apply.
About Bayer
Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Multiple Locations, , Korea, Republic Of
Multiple Locations, , Indonesia
Multiple Locations, , Singapore
Multiple Locations, , Thailand
Multiple Locations, , Malaysia
Multiple Locations, , Philippines
Patients applied
Trial Officials
Bayer Study Director
Study Director
Bayer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials